The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 07, 2007

Filed:

Apr. 06, 2005
Applicants:

Alan J. Hutchison, Madison, CT (US);

Bertrand L. Chenard, Waterford, CT (US);

James G. Tarrant, Hamden, CT (US);

Guiying LI, Branford, CT (US);

Manuka Ghosh, Madison, CT (US);

George P. Luke, Clinton, CT (US);

John M. Peterson, Durham, CT (US);

Wallace C. Pringle, Guilford, CT (US);

Mary-margaret E. O'donnell, Shelton, CT (US);

Kyungae Lee, Newton, MA (US);

Linda M. Gustavson, Ringoes, NJ (US);

Dario Doller, Wallingford, CT (US);

Inventors:

Alan J. Hutchison, Madison, CT (US);

Bertrand L. Chenard, Waterford, CT (US);

James G. Tarrant, Hamden, CT (US);

Guiying Li, Branford, CT (US);

Manuka Ghosh, Madison, CT (US);

George P. Luke, Clinton, CT (US);

John M. Peterson, Durham, CT (US);

Wallace C. Pringle, Guilford, CT (US);

Mary-Margaret E. O'Donnell, Shelton, CT (US);

Kyungae Lee, Newton, MA (US);

Linda M. Gustavson, Ringoes, NJ (US);

Dario Doller, Wallingford, CT (US);

Assignee:

Neurogen Corporation, Branford, CT (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A07D 241/36 (2006.01); A61K 31/498 (2006.01); A61P 3/04 (2006.01); A61P 3/10 (2006.01); C07D 239/70 (2006.01); C07D 487/08 (2006.01); C07D 471/14 (2006.01); A61K 31/517 (2006.01); A61K 31/407 (2006.01);
U.S. Cl.
CPC ...
Abstract

Compounds of Formula I are provided, in which variables are as described herein: Such compounds may be used to modulate MCH binding to MCH receptors in vivo or in vitro, and are particularly useful in the treatment of a variety of metabolic, feeding and sexual disorders in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for treating such disorders are provided, as are methods for using such ligands for detecting MCH receptors (e.g., receptor localization studies).


Find Patent Forward Citations

Loading…